Clinical Trials
3 trialsNCT04869488 2025-01-24
A Trial of SHR3162 Combined With Apatinib Mesylate Tablets or SHR3162 Monotherapy in Patients With Metastatic Castration Resistant Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Completed
NCT03407976 2020-07-15
APPEASE
University of Utah
Phase 1 Terminated
NCT02774200 2016-05-17
A One-arm Exploratory Clinical Research Program Study of Apatinib in Advanced Metastatic Renal Cell Carcinoma Patients.
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown